MYOSITIS FOLLOWING TREATMENT WITH HIGH-DOSE INTERLEUKIN-2 FOR MALIGNANCY

被引：0
|
作者：
FINGER, DR
PLOTZ, PH
HEYWOOD, G
机构：
[1] NIAMS,BETHESDA,MD
[2] NCI,BETHESDA,MD 20892
来源：
JOURNAL OF RHEUMATOLOGY | 1995年 / 22卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2188 / 2188
页数：1
相关论文
共 50 条
  • [1] CHRONIC INFLAMMATORY ARTHRITIS AFTER TREATMENT WITH HIGH-DOSE INTERLEUKIN-2 FOR MALIGNANCY
    MASSAROTTI, EM
    LIU, NY
    MIER, J
    ATKINS, MB
    [J]. AMERICAN JOURNAL OF MEDICINE, 1992, 92 (06): : 693 - 697
  • [2] Metastasectomy following incomplete response to high-dose interleukin-2
    Hughes, Tasha
    Broucek, Joseph
    Iodice, Gail
    Bommareddy, Praveen K.
    Basu, Sanjib
    Kaufman, Howard L.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2018, 117 (04) : 572 - 578
  • [3] SEVERE MYOCARDITIS FOLLOWING HIGH-DOSE INTERLEUKIN-2 ADMINISTRATION
    SAMLOWSKI, WE
    WARD, JH
    CRAVEN, CM
    FREEDMAN, RA
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1989, 113 (08) : 838 - 841
  • [4] COMPLEMENT ACTIVATION AND HIGH-DOSE OF INTERLEUKIN-2
    THIJS, LG
    HACK, CE
    VANSCHIJNDEL, RJMS
    NUIJENS, JH
    WOLBINK, GJ
    EERENBERGBELMER, AJM
    VANDERVALL, H
    WAGSTAFF, J
    [J]. LANCET, 1989, 2 (8659): : 395 - 395
  • [5] Managing toxicities of high-dose interleukin-2
    Schwartz, RN
    Stover, L
    Dutcher, J
    [J]. ONCOLOGY-NEW YORK, 2002, 16 (11): : 11 - 20
  • [6] High-dose interleukin-2 is an intensive treatment regardless of the venue of administration
    Schwartzentruber, DJ
    [J]. CANCER JOURNAL, 2001, 7 (02): : 103 - 104
  • [7] High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced Melanoma
    Silk, Ann W.
    Kaufman, Howard L.
    Curti, Brendan
    Mehnert, Janice M.
    Margolin, Kim
    McDermott, David
    Clark, Joseph
    Newman, Jenna
    Bommareddy, Praveen K.
    Denzin, Lisa
    Najmi, Saltanat
    Haider, Azra
    Shih, Weichung
    Kane, Michael P.
    Zloza, Andrew
    [J]. FRONTIERS IN ONCOLOGY, 2020, 9
  • [8] Treatment of pediatric ocular melanoma with high-dose interleukin-2 and thalidomide
    Soni, S
    Lee, DS
    DiVito, J
    Bui, AH
    DeRaffele, G
    Radel, E
    Kaufman, HL
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2002, 24 (06) : 488 - 491
  • [9] ERADICATION OF DISSEMINATED MURINE LEUKEMIA BY TREATMENT WITH HIGH-DOSE INTERLEUKIN-2
    THOMPSON, JA
    PEACE, DJ
    KLARNET, JP
    KERN, DE
    GREENBERG, PD
    CHEEVER, MA
    [J]. JOURNAL OF IMMUNOLOGY, 1986, 137 (11): : 3675 - 3680
  • [10] High-dose interleukin-2 may not be superior to low-dose interleukin-2 plus interferon
    Alikhan, M
    Spencer, HJ
    Kohli, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) : 6267 - 6268
12345